Access Six-Lead EKGs In Seconds With Medidata And AliveCor^®

Medidata's collaboration with AliveCor aims to revolutionize decentralized clinical trials by integrating the KardiaMobile^® 6L, an FDA-cleared six-lead EKG device. This partnership enhances patient engagement and experience by providing rapid, medical-grade heart rhythm analysis, allowing for objective cardiac safety assessments across diverse therapeutic areas such as oncology and rare diseases. The KardiaMobile 6L's compact design, compatibility with mobile devices, and user-friendly operation facilitate seamless data collection, enabling patients to participate in trials more easily and access real-time heart data. This innovation not only simplifies patient involvement but also improves retention rates. For trial sponsors, the integration offers cost-effective solutions that streamline timelines and enable tailored study designs.

Medidata's Sensor Cloud further amplifies this initiative by integrating various medical devices for biomarker discovery and employing advanced algorithms to derive clinical insights from sensor data, ultimately enhancing the overall efficiency and effectiveness of clinical trials while prioritizing patient safety and experience.